ESLA
Estrella Immunopharma, Inc.
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 18, 2026
Company with tickers: ESLA, ESLAW
CIK
1844417
CUSIP
297584104
Shares Outstanding
43,034,228
Website
https://www.estrellabio.com
Investor Relations
https://www.estrellabio.com/investors
13F Activity (30d)
1 filings
1 filers
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.